Financial Performance - Total revenue for Q3 2024 increased by 33% year-over-year to $28.1 million, up from $21.1 million in the prior-year period[3] - Adjusted net income grew 65% year-over-year to $14.9 million, compared to $9.0 million in the prior-year period, with adjusted diluted earnings per share at $0.20[3] - Adjusted EBITDA rose 54% year-over-year to $16.7 million, with an adjusted EBITDA margin of 59.2%, compared to 51.1% in the prior-year period[3] - Total revenues for Q3 2024 reached $28.15 million, a 33.2% increase from $21.12 million in Q3 2023[20] - Active management revenue increased to $26.97 million, up 42.5% from $18.93 million year-over-year[20] - Adjusted Net Income for Q3 2024 was $14.88 million, compared to $9.02 million in Q3 2023, reflecting a 64.5% increase[21] - Adjusted EBITDA for Q3 2024 was $16.67 million, with an adjusted EBITDA margin of 59.2%, compared to 51.1% in Q3 2023[23] - Total operating expenses for Q3 2024 were $19.11 million, an increase from $11.46 million in Q3 2023[20] - Gross profit for Q3 2024 was $25.96 million, compared to $17.76 million in Q3 2023, indicating a gross margin improvement[20] Policy Originations and Capital Deployment - The number of policy originations increased by 54% to 278 in Q3 2024, compared to 181 in the prior-year period, with origination capital deployment reaching $93.2 million[3] Acquisitions and Growth Initiatives - The company expects to close acquisitions of Carlisle Management and FCF Advisors, adding approximately $2.6 billion in assets under management by the end of Q4 2024, subject to regulatory approval[2] - The ABL Tech platform serves over 20 clients, with 23 more in negotiations, demonstrating significant growth in just eight months since its launch[2] - The company launched PREADISAN™, a health prediction and actuarial technology tool, in partnership with Lorisco, aimed at enhancing personalized financial solutions[2] Returns and Losses - GAAP net loss attributable to shareholders was $5.1 million, primarily due to a non-cash increase in warrant liability of $7.8 million[3] - Net loss attributable to common stockholders for Q3 2024 was $5.13 million, compared to a profit of $0.90 million in Q3 2023[21] - The company reported a loss on change in fair value of warrant liability of $8.77 million for Q3 2024, compared to a loss of $0.94 million in Q3 2023[21] Returns on Investment - Annualized return on invested capital (ROIC) for Q3 2024 was 21%, and annualized return on equity (ROE) was 23%[3] - Adjusted Annualized Return on Invested Capital (ROIC) improved to 20.6% as of September 30, 2024, up from 18.0% as of June 30, 2024[24] - Adjusted Annualized Return on Equity (ROE) increased to 23.1% for the period ended September 30, 2024, compared to 18.4% for the period ended June 30, 2024[25] Cash and Assets - Cash and cash equivalents as of September 30, 2024, were $19.4 million, with total assets amounting to $477.3 million[4][18]

Revenue Growth - Total revenues for Q2 2024 reached $29.08 million, a significant increase from $11.38 million in Q2 2023, representing a growth of 155.5%[200] - Active management revenue surged to $27.01 million in Q2 2024, compared to $11.02 million in Q2 2023, marking a 145.0% increase[200] - Portfolio servicing revenue increased by 240.5% to $84,218 in Q2 2024 from $24,737 in Q2 2023, driven by a rise in serviced policies[204] - The company’s origination revenue for Q2 2024 was $1.86 million, compared to no origination revenue in Q2 2023[200] - Active management revenue rose by $15,989,358, or 145.0%, for the three months ended June 30, 2024, driven by a net increase of $24,245,464 related to policies accounted for under the fair value method[206] - Total revenue for the active management segment increased by $15,989,358 or 145.0% for the three months ended June 30, 2024, compared to the same period in 2023[249] - Total revenue for the originations segment increased by $1,857,457 for the three months ended June 30, 2024, compared to the same period in 2023, with no prior revenue recorded[251] Profitability Metrics - Gross profit for Q2 2024 was $26.33 million, up from $10.41 million in Q2 2023, reflecting a growth of 153.0%[200] - Gross profit increased by $15,927,203, or 153.1%, for the three months ended June 30, 2024, primarily due to an increase in active management revenue driven by an increase in policies purchased[217] - Adjusted Net Income for Q2 2024 was $11,812,527, compared to $6,750,145 in Q2 2023, reflecting a significant increase of 75.7%[260] - Adjusted EPS for Q2 2024 was $0.19 (basic) and $0.18 (diluted), up from $0.13 (both) in Q2 2023, representing a 46.2% increase in basic EPS[260] - Adjusted EBITDA for Q2 2024 was $16,716,882, compared to $9,143,985 in Q2 2023, marking an increase of 82.8%[265] - The Adjusted EBITDA margin for Q2 2024 was 57.5%, down from 80.4% in Q2 2023, indicating a decrease in operational efficiency[265] Expenses and Losses - Operating income for Q2 2024 was $6.77 million, a decrease from $8.37 million in Q2 2023, indicating a decline of 18.9%[200] - Sales and marketing expenses increased by $1,868,960, or 273.3%, for the three months ended June 30, 2024, primarily related to an increase in advertising costs to support origination and active management growth strategy[220] - General and administrative expenses increased by $13,975,805, or 2,419.9%, for the three months ended June 30, 2024, primarily due to non-cash stock-based compensation expense and payroll expenses[222] - Interest expense increased to $4,529,187 for the three months ended June 30, 2024, compared to $584,075 for the same period in 2023, primarily due to various interest expenses[234] - Income tax expense increased by $573,139 or 48.4% for the three months ended June 30, 2024, compared to the same period in 2023[242] Investment Performance - Unrealized loss on investments increased by $1,035,418, or 153.9%, for the three months ended June 30, 2024, primarily due to changes in the fair value of S&P 500 options[226] - The average realized gain on policies sold under the investment method was 48.2% for the six months ended June 30, 2024, compared to 16.3% in the same period in 2023[208] - Realized gain on investments increased by $856,744 for the three months ended June 30, 2024, compared to the same period in 2023, primarily due to the sale of S&P 500 options[228] - Loss on change in fair value of debt decreased by $245,766 or 17.0% for the three months ended June 30, 2024, compared to the same period in 2023[231] - Loss on change in fair value of debt increased by $1,513,428 or 63.1% for the six months ended June 30, 2024, compared to the same period in 2023[232] Cash Flow and Financing - Net cash used in operating activities for H1 2024 was $(64,542,510), an increase of $26,178,339 compared to $(38,364,171) in H1 2023[275] - Net cash provided by financing activities surged to $130,993,784 in H1 2024, compared to $35,983,097 in H1 2023, reflecting a significant increase of 263.5%[279] - The company has a $15,000,000 share repurchase plan approved in December 2023, with $2,974,863 remaining available for repurchases as of June 30, 2024[273] Policy and Market Activity - The number of policies serviced increased by 41.0% to 1,155 in the first half of 2024, compared to 819 in the same period of 2023[270] - The value of policies serviced rose by 38.6% to $2,526,819,484 in H1 2024, up from $1,823,437,795 in H1 2023[270] - Total invested dollars increased by 59.4% to $1,081,579,116 in H1 2024, compared to $678,400,432 in H1 2023[270] - The company operates in 49 states and the District of Columbia, holding licenses in 43 jurisdictions for life and viatical settlements[195] - Abacus operates in 49 states and the District of Columbia, holding licenses in 43 jurisdictions for life and viatical settlements[287] Historical Performance - For the three months ended June 30, 2023, total revenue was $6,884,690, with origination revenue contributing $1,689,088 and related-party revenue at $5,195,602[289] - Gross profit for the same period was $1,986,710, resulting in a gross margin of 29%[296] - The net loss for the three months ended June 30, 2023, was $318,098, with an adjusted EBITDA of $(310,867)[312] - For the six months ended June 30, 2023, total revenue reached $13,184,676, with origination revenue at $3,252,738 and related-party revenue at $9,931,938[289] - The gross profit for the six months was $3,891,373, yielding a gross margin of 30%[298] - The net loss for the six months ended June 30, 2023, was $974,901, with an adjusted EBITDA of $(957,207)[312]

As filed with the Securities and Exchange Commission on June 13, 2024. (Exact Name of Registrant as Specified in Its Charter) Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) 2101 Park Center Drive, Suite 200 Orlan ...

As filed with the Securities and Exchange Commission on May 30, 2024. Registration No. 333-279347 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER Jay J. Jackson Chief Executive Officer Abacus Life, Inc. 2101 Park Center Drive, Suite 170 Orlando, Florida 32835 (800) 561-4148 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: THE SECURITIES ACT OF 1933 Abacus Life, Inc. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) Delaware 85-1210472 ...

As filed with the Securities and Exchange Commission on May 10, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Orlando, Florida 32835 (8 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39403 Abacus Life, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdic ...

Table of Contents As filed with the Securities and Exchange Commission on February 9, 2024. Registration No. 333-276795 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 6282 85-1210472 (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Id ...

Table of Contents As filed with the Securities and Exchange Commission on January 31, 2024. Registration No. 333-[ ] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Abacus Life, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporation or Organization) Delaware 6282 85-1210472 (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 2101 ...

Revenue Growth - Total revenues for the three months ended September 30, 2023, were $21,120,930, a significant increase from $11,507,748 in the same period of 2022, representing an 83.5% growth[236] - Active management revenue for the nine months ended September 30, 2023, reached $39,921,061, compared to $28,411,475 for the same period in 2022, reflecting a 40.6% increase[236] - Active management revenue for the three months ended September 30, 2023, was $18,926,144, an increase of $7,800,641 or 70.1% compared to $11,125,503 in the same period of 2022[245] - Total active management revenue for the nine months ended September 30, 2023, was $39,921,061, an increase of $11,509,586 or 40.5% compared to $28,411,475 in the same period of 2022[248] - Total origination revenue reached $1,715,700 for the three months ended September 30, 2023, also a 100% increase from $0 in the prior year[251] - Related party origination revenue increased to $254,517 for the three months ended September 30, 2023, compared to $0 in the same period of 2022, marking a 100% increase[250] Profit and Loss - The company reported a gross profit of $17,755,973 for the three months ended September 30, 2023, compared to $9,752,854 in the same period of 2022, marking an increase of 82.5%[236] - For the three months ended September 30, 2023, net income attributable to Abacus Life, Inc. was $903,361, a decrease from $9,992,004 in the same period of 2022, representing a decline of 91.0%[237] - Adjusted Net Income for the three months ended September 30, 2023, was $9,168,357, a decrease of $1,187,099, or 11.5%, compared to the same period in 2022[308] - Adjusted Net Income for the nine months ended September 30, 2023, was $23,516,703, compared to $22,277,795 for the same period in 2022[309] - Net income for Abacus Life Inc. for the three months ended September 30, 2023, was $1,050,972, a decrease of 89.9% compared to $10,355,455 for the same period in 2022[329] Expenses - The cost of revenue for the three months ended September 30, 2023, was $3,364,957, up from $1,754,894 in the same period of 2022, which is an increase of 91.6%[236] - Sales and marketing expenses for the three months ended September 30, 2023, were $1,704,154, significantly higher than $14,905 in the same period of 2022[236] - General and administrative expenses, including stock-based compensation of $4,538,632, totaled $9,838,951 for the three months ended September 30, 2023, compared to $59,816 in the same period of 2022[236] - General and administrative expenses increased by $9,779,135, or 16,348.7%, to $9,838,951 for the three months ended September 30, 2023, largely due to stock-based compensation and legal consulting fees[264] - Interest expense was $2,679,237 for the three months ended September 30, 2023, compared to $0 for the same period in 2022, driven by the Owl Rock Credit Facility and other notes[279] Investment Performance - The unrealized loss on investments for the three months ended September 30, 2023, was $306,800, compared to a loss of $246,846 in the same period of 2022[236] - The unrealized loss on investments for the nine months ended September 30, 2023, decreased by $1,793,177, or 137.7%, totaling $(491,356) compared to a gain of $1,301,821 in the same period of 2022[270] - The company has not identified any impairment indicators for its equity investments in privately held companies, maintaining a carrying value of $1,650,000 as of September 30, 2023[361] - Abacus Life, Inc. has investments classified as available-for-sale securities, with a fair value approximating the carrying value of $1,000,000 as of September 30, 2023[362] Cash Flow and Financing - Cash used in operating activities for the nine months ended September 30, 2023, was $51,176,074, significantly higher than $6,395,331 used in the same period of 2022[341] - Financing activities generated $55,203,004 of net cash during the nine months ended September 30, 2023, compared to $12,069,661 in the same period of 2022, an increase of $43,133,343[344] - The company may seek additional equity or debt financing in the future to support revenue growth and expansion of active management and portfolio activities[340] - The company is obligated to provide financial support to the Providers, with significant contractual obligations including market-indexed notes totaling $12,900,291 as of September 30, 2023[345] Market and Growth Opportunities - The company has identified significant opportunities for growth in the life settlements industry, with a narrow portion of the potential market currently being captured[368] - Abacus expects to continue investing in technology and marketing infrastructure to support anticipated growth in the life settlements industry[369] Policy and Segment Performance - Total revenue for the active management segment increased by $7,800,641, or 70.1%, for the three months ended September 30, 2023, compared to the same period in 2022[296] - Total revenue for the originations segment increased by $10,214,489 for the three months ended September 30, 2023, with no revenue recorded prior to the Business Combination in June 2023[299] - The number of policies serviced increased by 106.9% to 904 in the nine months ended September 30, 2023, compared to 437 in 2022[316] - The value of policies serviced rose by 49.8% to $943,913,658 in 2023 from $630,312,740 in 2022[316]